Searched for
KINLYTIC
- Cadila stock touches 52 week high after gettting USFDA approval for two generic drugsAccording to pharma analyst, the company would continue to witness jump in its stock prices as it is bullish on getting FDA approval for it...
- Zydus Cadila concludes deal to re-launch Urokinase drugZydus Cadila concludes agreement with Canadian biotech company Microbix Biosystems to re-launch KINLYTIC, a life saving drug in North Ameri...
- Load More